DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
4QVL_K_BO2K301 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
4QVL_Y_BO2Y301 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
4QVM_K_BO2K301 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
4QVM_Y_BO2Y301 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33GLY Y 47GLY Y 48ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
4QVN_K_BO2K301 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33VAL K 45GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
4QVN_Y_BO2Y301 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33VAL Y 45GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QVP_K_BO2K301 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33THR K 45GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
4QVP_Y_BO2Y301 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33THR Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QVQ_K_BO2K301 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33ILE K 45GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
4QVQ_Y_BO2Y301 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33ILE Y 45GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QVV_K_BO2K301 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
8 |
THR K 1THR K 21LYS K 33MET K 45GLY K 47GLY K 48VAL K 49ASP L 126 |
BO2 K 301
|
4QVV_Y_BO2Y301 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
8 |
THR Y 1THR Y 21LYS Y 33MET Y 45GLY Y 47GLY Y 48VAL Y 49ASP Z 126 |
BO2 Y 301
|
4QVW_K_BO2K301 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48SER K 49ASP L 126SER L 130 |
BO2 K 301
|
4QVW_Y_BO2Y301 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48SER Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
4QVY_K_BO2K301 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27VAL K 31LYS K 33GLY K 48THR K 49ASP L 126 |
BO2 K 301
|
4QVY_Y_BO2Y301 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27VAL Y 31LYS Y 33GLY Y 48THR Y 49ASP Z 126 |
BO2 Y 301
|
4QW0_K_BO2K301 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5 |
PF00227(Proteasome) |
7 |
THR K 1ALA K 20THR K 21ALA K 22LYS K 33MET K 45THR K 49 |
BO2 K 301
|
4QW0_Y_BO2Y301 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5 |
no annotation |
7 |
THR Y 1ALA Y 20THR Y 21ALA Y 22LYS Y 33MET Y 45THR Y 49 |
BO2 Y 301
|
4QW1_K_BO2K301 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
4QW1_Y_BO2Y301 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QW3_K_BO2K301 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
4QW3_Y_BO2Y301 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QWU_K_BO2K301 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ASP L 126 |
BO2 K 301
|
4QWU_Y_BO2Y301 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ASP Z 126 |
BO2 Y 301
|
5BXN_K_BO2K301 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5BXN_Y_BO2Y301 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5D0X_K_BO2K301 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
SER K 1ALA K 20THR K 21ALA K 27LYS K 33GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
5D0X_Y_BO2Y301 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
SER Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
5L5F_K_BO2K301 |
5l5f |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
PF00227(Proteasome) |
9 |
THR K 1SER K 21SER K 27VAL K 31LYS K 33MET K 45ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5L5F_Y_BO2Y301 |
5l5f |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
no annotation |
8 |
THR Y 1SER Y 21SER Y 27LYS Y 33MET Y 45ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5L5Z_K_BO2K301 |
5l5z |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5;PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27LYS K 33GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
5L5Z_Y_BO2Y301 |
5l5z |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5;PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27LYS Y 33GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
5L66_K_BO2K301 |
5l66 |
BO2 DB00188(Bortezomib) |
Mus musculus;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21SER K 27LYS K 33MET K 45GLY K 47ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5L66_Y_BO2Y301 |
5l66 |
BO2 DB00188(Bortezomib) |
Mus musculus;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21SER Y 27LYS Y 33MET Y 45GLY Y 47ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5LF3_K_BO2K305 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 22LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 125TYR K 169 |
BO2 K 305
|
5LF3_Y_BO2Y305 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 22LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 125TYR Y 169 |
BO2 Y 305
|
5LF7_K_6V8K305 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
PF00227(Proteasome) |
11 |
THR K 2ALA K 21THR K 22ALA K 23VAL K 32LYS K 34MET K 46GLY K 48GLY K 49ALA K 50ASP L 125 |
6V8 K 305
|
5LF7_Y_6V8Y306 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
None |
11 |
THR Y 2ALA Y 21THR Y 22ALA Y 23VAL Y 32LYS Y 34MET Y 46GLY Y 48GLY Y 49ALA Y 50ASP Z 125 |
6V8 Y 306
|
6HWD_K_BO2K301 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
6HWD_Y_BO2Y301 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
None |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|